CareDx Inc (CDNA) - Total Liabilities
Based on the latest financial reports, CareDx Inc (CDNA) has total liabilities worth $121.17 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore CDNA net asset momentum to track the company's year-over-year net asset growth rate.
CareDx Inc - Total Liabilities Trend (2012–2024)
This chart illustrates how CareDx Inc's total liabilities have evolved over time, based on quarterly financial data.
CareDx Inc Competitors by Total Liabilities
The table below lists competitors of CareDx Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
indie Semiconductor Inc
NASDAQ:INDI
|
USA | $520.61 Million |
|
SUFA Technology Industry Co Ltd CNNC
SHE:000777
|
China | CN¥1.24 Billion |
|
Chongqing Wangbian Electric (Group) Corp. Ltd.
SHG:603191
|
China | CN¥4.28 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥6.71 Billion |
|
Jefferson Capital, Inc. Common Stock
NASDAQ:JCAP
|
USA | $1.37 Billion |
|
Vanjee Technology Co Ltd
SHE:300552
|
China | CN¥958.76 Million |
|
Vertex
NASDAQ:VERX
|
USA | $967.86 Million |
|
Bellring Brands LLC
NYSE:BRBR
|
USA | $1.52 Billion |
Liability Composition Analysis (2012–2024)
This chart breaks down CareDx Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of CareDx Inc.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CareDx Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CareDx Inc (2012–2024)
The table below shows the annual total liabilities of CareDx Inc from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $112.62 Million | -45.20% |
| 2023-12-31 | $205.50 Million | +83.35% |
| 2022-12-31 | $112.08 Million | +11.25% |
| 2021-12-31 | $100.75 Million | +10.91% |
| 2020-12-31 | $90.83 Million | +72.24% |
| 2019-12-31 | $52.74 Million | +51.68% |
| 2018-12-31 | $34.77 Million | -61.16% |
| 2017-12-31 | $89.52 Million | +57.14% |
| 2016-12-31 | $56.97 Million | +117.90% |
| 2015-12-31 | $26.14 Million | +31.75% |
| 2014-12-31 | $19.84 Million | -87.64% |
| 2013-12-31 | $160.55 Million | +2.21% |
| 2012-12-31 | $157.08 Million | -- |
About CareDx Inc
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution … Read more